Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in renal transplant recipients
NCT00239876Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2005
- Primary completion
- Dec 2005
01
Overview
A Phase 3 trial of fingolimod in kidney transplant, sponsored by Novartis. Started May 2005; status: completed.
02
Drugs
fingolimod
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT00239876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239876.